salvador iborra
Inmunotek SL
Alcalá de Henares, Spain
Review Editor
Vaccines and Molecular Therapeutics
Inmunotek SL
Alcalá de Henares, Spain
Review Editor
Vaccines and Molecular Therapeutics
London School of Hygiene and Tropical Medicine, University of London
London, United Kingdom
Review Editor
Vaccines and Molecular Therapeutics
National Institute of Infectious Diseases (NIID)
Tokyo, Japan
Review Editor
Vaccines and Molecular Therapeutics
Nagasaki University
Nagasaki, Japan
Review Editor
Vaccines and Molecular Therapeutics
Zhejiang University-University of Edinburgh Institute
Haining, China
Review Editor
Vaccines and Molecular Therapeutics
Riga Stradiņš University
Riga, Latvia
Review Editor
Vaccines and Molecular Therapeutics
Takeda (United States)
San Diego, United States
Review Editor
Vaccines and Molecular Therapeutics
Boehringer Ingelheim (United States)
Ridgefield, United States
Review Editor
Vaccines and Molecular Therapeutics
Gachon University
Seongnam, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
Seoul National University
Seoul, Republic of Korea
Review Editor
Vaccines and Molecular Therapeutics
University of Cologne
Cologne, Germany
Review Editor
Vaccines and Molecular Therapeutics
University of Warsaw
Warsaw, Poland
Review Editor
Vaccines and Molecular Therapeutics
F. Edward Hebert School of Medicine, Uniformed Services University
Bethesda, United States
Review Editor
Vaccines and Molecular Therapeutics
Henry M Jackson Foundation for the Advancement of Military Medicine (HJF)
Bethesda, United States
Review Editor
Vaccines and Molecular Therapeutics
Peking University
Beijing, China
Review Editor
Vaccines and Molecular Therapeutics
Zhejiang Chinese Medical University
Hangzhou, China
Review Editor
Vaccines and Molecular Therapeutics